Annual Drug Patent Expirations for ARESTIN
Arestin is a drug marketed by Orapharma and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has thirteen patent family members in thirteen countries.
The generic ingredient in ARESTIN is minocycline hydrochloride. One supplier is listed for this compound. Additional details are available on the minocycline hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com